These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9884282)

  • 61. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
    LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
    Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of the established standard complement-dependent cytotoxicity and flow cytometric crossmatch assays with a novel ELISA-based HLA crossmatch procedure.
    Altermann WW; Seliger B; Sel S; Wendt D; Schlaf G
    Histol Histopathol; 2006 Oct; 21(10):1115-24. PubMed ID: 16835834
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
    Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
    Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HLA antibody screening: comparison of a solid phase enzyme-linked immunoassay with antiglobulin-augmented lymphocytotoxicity.
    Moore SB; Ploeger NA; DeGoey SR
    Transplantation; 1997 Dec; 64(11):1617-20. PubMed ID: 9415570
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
    Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
    Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical relevance of anti-HLA antibodies pre and post transplant.
    Kerman RH; Orosz CG; Lorber MI
    Am J Med Sci; 1997 May; 313(5):275-8. PubMed ID: 9145036
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system.
    Yang CW; Oh EJ; Lee SB; Moon IS; Kim DG; Choi BS; Park SC; Choi YJ; Park YJ; Han K
    Transplant Proc; 2006 Nov; 38(9):2803-6. PubMed ID: 17112834
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Soluble HLA antigens and ELISA--a new technology for crossmatch testing.
    Buelow R; Chiang TR; Monteiro F; Cornejo MC; Ellingson L; Claas F; Gaber O; Gelder F; Kotb M; Orosz C
    Transplantation; 1995 Dec; 60(12):1594-9. PubMed ID: 8545896
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Selective omission of the donor cross-match before renal transplantation: efficacy, safety and effects on cold storage time.
    Taylor CJ; Smith SI; Morgan CH; Stephenson S; Key T; Jones P; Watson C; Jacques B; Welsh KI; Bradley JA
    Transplantation; 2000 Mar; 69(5):719-23. PubMed ID: 10755516
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Flow Cytometric Panel-Reactive Antibody Results and the Ability to Find Transfusion-Compatible Platelets after Antibody-Desensitization for Allogeneic Bone Marrow Transplant.
    Rosenbaum ER; Pandey S; Harville TO; Drobena GA; Cottler-Fox M
    Ann Clin Lab Sci; 2016 Dec; 46(6):662-665. PubMed ID: 27993881
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Desensitization for renal transplantation: depletion of donor-specific anti-HLA antibodies, preservation of memory antibodies, and clinical risks.
    Rogers NM; Eng HS; Yu R; Kireta S; Tsiopelas E; Bennett GD; Brook NR; Gillis D; Russ GR; Coates PT
    Transpl Int; 2011 Jan; 24(1):21-9. PubMed ID: 20698938
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Flow cytometric detection of complement-activating HLA antibodies.
    Schönemann C; Lachmann N; Kiesewetter H; Salama A
    Cytometry B Clin Cytom; 2004 Nov; 62(1):39-45. PubMed ID: 15476206
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients.
    Ravindranath MH; Pham T; Ozawa M; Terasaki PI
    Int Immunol; 2012 Jan; 24(1):43-57. PubMed ID: 22190577
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between flow cytometric crossmatching and graft survival in Thai cadaveric-donor kidney transplantation.
    Kupatawintu P; Tatawatorn A; Premasathian N; Avihingsanon Y; Leelahavanichkul A; Hirankarn N
    Asian Pac J Allergy Immunol; 2016 Mar; 34(1):86-93. PubMed ID: 26994631
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay.
    Visentin J; Bachelet T; Borg C; Franchini N; Nong T; Lee JH; Couzi L; Merville P; Guidicelli G; Taupin JL
    Transplantation; 2017 Mar; 101(3):624-630. PubMed ID: 27336398
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reactivity of twenty-two cytotoxic human monoclonal HLA antibodies towards soluble HLA class I in an enzyme-linked immunosorbent assay (PRA-STAT).
    Mulder A; Kardol M; Regan J; Buelow R; Claas F
    Hum Immunol; 1997; 56(1-2):106-13. PubMed ID: 9455499
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of Preoperative Positive Cross-Match and HLA Mismatching on Early Acute Cellular Rejection and Graft Survival in Living Donor Liver Transplantation.
    Na GH; Kim EY; Hong TH; You YK; Kim DG
    Ann Transplant; 2015 Sep; 20():553-60. PubMed ID: 26377312
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.
    Gloor JM; Moore SB; Schneider BA; Degoey SR; Stegall MD
    Transplantation; 2007 Jul; 84(2):258-64. PubMed ID: 17667819
    [TBL] [Abstract][Full Text] [Related]  

  • 80. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
    Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A
    Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.